Impact of extramedullary plasmacytoma on outcomes in patients with relapsed refractory multiple myeloma treated with talquetamab: U.S. Myeloma Immunotherapy Consortium

Aimaz Afrough, Oren Pasvolsky, Andrew J. Portuguese, Saurabh Zanwar, Mahmoud R. Gaballa, Aishwarya Sannareddy, Danai Dima, Utkarsh Goel, Hossam M. Ali, Kelley Julian, Andre De Menezes Silva Corraes, Murali Janakiram, Scott Goldsmith, James A. Davis, Kimberly Green, Noa Biran, Lindsay Fogel, Eli Zolotov, Megan M. Herr, Hamza Hassan, Leyla Shune, Jeries Kort, Christina Ye, Susan Bal, Luciano J. Costa, Laura Joiner, Samer AL Hadidi, Adeel M. Khan, Shahzad Raza, Faiz Anwer, Jack Khouri, Rahul Banerjee, Raffaela Cassano Cassano, Surbhi Sidana, Masooma Shifa Rana, Lekha Mikkilineni, Hitomi Hosoya, Shebli Atrash, Christopher Ferreri, Cindy Varga, Douglas W. Sborov, Shonali Midha, Omar Nadeem, Ariel Grajales-Cruz, Rachid Baz, Brandon Blue, Ciara Freeman, Frederick L. Locke, Krina K. Patel, Yi Lin, Shaji K. Kumar, Doris K. Hansen, Larry D. Anderson Jr, Peter M. Voorhees, Omar Castaneda-Puglianini

Open source

DOI: 10.1038/s41408-026-01565-0
Published: 2026-07-27
Container: Blood Cancer Journal
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41408-026-01565-0,
  title = {Impact of extramedullary plasmacytoma on outcomes in patients with relapsed refractory multiple myeloma treated with talquetamab: U.S. Myeloma Immunotherapy Consortium},
  author = {Aimaz Afrough and Oren Pasvolsky and Andrew J. Portuguese and Saurabh Zanwar and Mahmoud R. Gaballa and Aishwarya Sannareddy and Danai Dima and Utkarsh Goel and Hossam M. Ali and Kelley Julian and Andre De Menezes Silva Corraes and Murali Janakiram and Scott Goldsmith and James A. Davis and Kimberly Green and Noa Biran and Lindsay Fogel and Eli Zolotov and Megan M. Herr and Hamza Hassan and Leyla Shune and Jeries Kort and Christina Ye and Susan Bal and Luciano J. Costa and Laura Joiner and Samer AL Hadidi and Adeel M. Khan and Shahzad Raza and Faiz Anwer and Jack Khouri and Rahul Banerjee and Raffaela Cassano Cassano and Surbhi Sidana and Masooma Shifa Rana and Lekha Mikkilineni and Hitomi Hosoya and Shebli Atrash and Christopher Ferreri and Cindy Varga and Douglas W. Sborov and Shonali Midha and Omar Nadeem and Ariel Grajales-Cruz and Rachid Baz and Brandon Blue and Ciara Freeman and Frederick L. Locke and Krina K. Patel and Yi Lin and Shaji K. Kumar and Doris K. Hansen and Larry D. Anderson Jr and Peter M. Voorhees and Omar Castaneda-Puglianini},
  year = {2026},
  journal = {Blood Cancer Journal},
  doi = {10.1038/s41408-026-01565-0},
  url = {https://doi.org/10.1038/s41408-026-01565-0}
}

RIS

TY  - JOUR
TI  - Impact of extramedullary plasmacytoma on outcomes in patients with relapsed refractory multiple myeloma treated with talquetamab: U.S. Myeloma Immunotherapy Consortium
AU  - Aimaz Afrough
AU  - Oren Pasvolsky
AU  - Andrew J. Portuguese
AU  - Saurabh Zanwar
AU  - Mahmoud R. Gaballa
AU  - Aishwarya Sannareddy
AU  - Danai Dima
AU  - Utkarsh Goel
AU  - Hossam M. Ali
AU  - Kelley Julian
AU  - Andre De Menezes Silva Corraes
AU  - Murali Janakiram
AU  - Scott Goldsmith
AU  - James A. Davis
AU  - Kimberly Green
AU  - Noa Biran
AU  - Lindsay Fogel
AU  - Eli Zolotov
AU  - Megan M. Herr
AU  - Hamza Hassan
AU  - Leyla Shune
AU  - Jeries Kort
AU  - Christina Ye
AU  - Susan Bal
AU  - Luciano J. Costa
AU  - Laura Joiner
AU  - Samer AL Hadidi
AU  - Adeel M. Khan
AU  - Shahzad Raza
AU  - Faiz Anwer
AU  - Jack Khouri
AU  - Rahul Banerjee
AU  - Raffaela Cassano Cassano
AU  - Surbhi Sidana
AU  - Masooma Shifa Rana
AU  - Lekha Mikkilineni
AU  - Hitomi Hosoya
AU  - Shebli Atrash
AU  - Christopher Ferreri
AU  - Cindy Varga
AU  - Douglas W. Sborov
AU  - Shonali Midha
AU  - Omar Nadeem
AU  - Ariel Grajales-Cruz
AU  - Rachid Baz
AU  - Brandon Blue
AU  - Ciara Freeman
AU  - Frederick L. Locke
AU  - Krina K. Patel
AU  - Yi Lin
AU  - Shaji K. Kumar
AU  - Doris K. Hansen
AU  - Larry D. Anderson Jr
AU  - Peter M. Voorhees
AU  - Omar Castaneda-Puglianini
PY  - 2026
JO  - Blood Cancer Journal
DO  - 10.1038/s41408-026-01565-0
UR  - https://doi.org/10.1038/s41408-026-01565-0
ER  -

APA

Afrough, A., Pasvolsky, O., Portuguese, A. J., Zanwar, S., Gaballa, M. R., Sannareddy, A., Dima, D., Goel, U., Ali, H. M., Julian, K., Corraes, A. D. M. S., Janakiram, M., Goldsmith, S., Davis, J. A., Green, K., Biran, N., Fogel, L., Zolotov, E., Herr, M. M., Hassan, H., Shune, L., Kort, J., Ye, C., Bal, S., Costa, L. J., Joiner, L., Hadidi, S. A., Khan, A. M., Raza, S., Anwer, F., Khouri, J., Banerjee, R., Cassano, R. C., Sidana, S., Rana, M. S., Mikkilineni, L., Hosoya, H., Atrash, S., Ferreri, C., Varga, C., Sborov, D. W., Midha, S., Nadeem, O., Grajales-Cruz, A., Baz, R., Blue, B., Freeman, C., Locke, F. L., Patel, K. K., Lin, Y., Kumar, S. K., Hansen, D. K., Jr, L. D. A., Voorhees, P. M., & Castaneda-Puglianini, O. (2026). Impact of extramedullary plasmacytoma on outcomes in patients with relapsed refractory multiple myeloma treated with talquetamab: U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal. https://doi.org/10.1038/s41408-026-01565-0

Source records

crossref · retrieved 2026-11-10T20:04:57.931Z